Registrations have closed.
TIL Therapies Digital Summit
by
123 123 people viewed this event.
Targeted immunotherapy and lymphocyte modifications have progressed therapeutically with an astounding speed and improved efficacy. Solid tumors, however, still remain a stubborn and viscous clinical target. Time: 08:30 – 18:15
Additional Details
Etkinlik Ülkesi - Other
